Regulatory Affairs Professionals Society· @RAPSorg · X·· 2 小时前精选AI 评分60
AI 导读
RAPS 引用数据显示，欧盟及欧洲经济区获授权的临床试验数量较疫情前水平下降13.5%，同期亚洲在临床研究中占据的份额持续上升。原文未披露具体统计口径与时间范围。
推荐理由
原文给出欧盟及欧洲经济区临床试验授权量较疫情前下降13.5%的数据，读者可据此观察全球临床研究向亚洲转移的趋势。
正文
The number of clinical trials authorized in the EU and European Economic Area has decreased by 13.5% from pre-pandemic levels as Asia has captured a growing share of clinical research.
https://hubs.la/Q04z-_Xp0
来源：Regulatory Affairs Professionals Society · x.com